Prospective evaluation of 68Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative 131I-whole body scan: comparison with 18F-FDG PET-CT

[1] Menendez Torre E(2004)Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer Thyroid 14 301-6

[2] Lopez Carballo MT(2003)Phantoms in the assay tube:heterophile antibody interference in serum thyroglobulin assays J Clin Endocrinol Metab 88 3069-74

[3] Rodriguez Erdozain RM(2005)Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning J Nucl Med 46 1473-80

[4] Preissner CM(2005)Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation Cancer Res 65 4238-45

[5] O’Kane DJ(2007)Gene methylation in thyroid tumorigenesis Endocrinology 148 948-53

[6] Singh RJ(2001)Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma Eur J Nucl Med 28 639-45

[7] Ma C(1993)Paradoxical changes in iodine-131 scintigraphic findings in advanced follicular thyroid cancer J Nucl Med 34 1574-6

[8] Kuang A(1999)Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study Eur J Nucl Med 26 1547-52

[9] Xie J(2006)Antitumor activity of suberoylanilidehydroxamic acid against thyroid cancer cell lines in vitro and in vivo Clin Cancer Res 12 5570-7

[10] Ma T(2005)Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells J Clin Endocrinol Metab 90 1383-9

[1] Menendez Torre E(2004)Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer Thyroid 14 301-6

[2] Lopez Carballo MT(2003)Phantoms in the assay tube:heterophile antibody interference in serum thyroglobulin assays J Clin Endocrinol Metab 88 3069-74

[3] Rodriguez Erdozain RM(2005)Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning J Nucl Med 46 1473-80

[4] Preissner CM(2005)Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation Cancer Res 65 4238-45

[5] O’Kane DJ(2007)Gene methylation in thyroid tumorigenesis Endocrinology 148 948-53

[6] Singh RJ(2001)Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma Eur J Nucl Med 28 639-45

[7] Ma C(1993)Paradoxical changes in iodine-131 scintigraphic findings in advanced follicular thyroid cancer J Nucl Med 34 1574-6

[8] Kuang A(1999)Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study Eur J Nucl Med 26 1547-52

[9] Xie J(2006)Antitumor activity of suberoylanilidehydroxamic acid against thyroid cancer cell lines in vitro and in vivo Clin Cancer Res 12 5570-7

[10] Ma T(2005)Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells J Clin Endocrinol Metab 90 1383-9